Regeneron Pharmaceuticals (REGN)

Stockholders Equity

$31.71B

Quarterly · Period ending: · USD

REGN logo

REGN Stockholders Equity

Latest reported$31.71B
REGN Quarterly Shareholders Equity ($12.20M → $31.71B)
High-resolution chart · PNG

REGN stockholders equity history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Stockholders Equity — Quarterly (USD)
Period endingStockholders Equity (USD)
31,711,000,000
31,423,600,000
31,256,900,000
30,957,800,000
29,938,900,000
29,387,600,000
29,353,600,000
29,325,900,000
28,205,800,000
26,991,100,000
25,973,100,000
24,904,400,000
24,017,900,000
23,495,200,000
22,664,000,000
21,438,800,000
20,687,800,000
19,914,700,000
18,768,800,000
17,258,000,000
15,127,300,000
11,977,000,000
11,025,300,000
10,125,500,000
9,057,400,000
12,133,000,000
11,089,700,000
10,504,400,000
9,755,900,000
9,444,700,000
8,757,300,000
7,868,300,000
7,186,426,000
6,567,644,000
6,144,078,000
6,051,593,000
5,520,738,000
4,866,021,000
4,449,245,000
4,491,247,000
4,076,506,000
3,765,082,000
3,654,837,000
3,296,867,000
3,338,458,000
2,971,430,000
2,542,325,000
2,551,788,000
2,368,842,000
2,211,248,000
1,952,076,000
1,690,171,000
1,493,337,000
1,406,348,000
1,245,385,000
806,024,000
594,657,000
504,024,000
485,732,000
428,253,000
478,034,000
518,091,000
527,815,000
348,064,000
371,216,000
386,271,000
396,762,000
422,443,000
410,506,000
410,320,000
418,852,000
436,933,000
450,997,000
460,603,000
460,267,000
151,397,000
179,336,000
196,689,000
216,624,000
62,473,000
83,767,000
102,323,000
114,002,000
136,381,000
165,060,000
185,784,000
182,543,000
178,873,000
190,130,000
204,106,000
137,643,000
156,202,000
137,843,000
165,615,000
145,981,000
180,788,000
213,159,000
242,484,000
266,355,000
294,871,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.